Production (Stage)
Altamira Therapeutics Ltd.
CYTOF
$0.10
$0.00060.60%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 998.60K | 998.60K | 65.50K | 65.50K | 733.70K |
Total Receivables | 351.30K | 351.30K | 121.30K | 121.30K | 88.90K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.60K | 1.60K | 75.20K | 75.20K | 84.70K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 189.00K | 189.00K | 262.00K | 262.00K | 546.20K |
Total Current Assets | 1.54M | 1.54M | 524.00K | 524.00K | 1.45M |
|
|||||
Total Current Assets | 1.54M | 1.54M | 524.00K | 524.00K | 1.45M |
Net Property, Plant & Equipment | 449.90K | 449.90K | 417.60K | 417.60K | 95.20K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 4.63M | 4.63M | 4.63M | 4.63M | 4.63M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 8.65M | 8.65M | 8.07M | 8.07M | 9.14M |
|
|||||
Total Accounts Payable | 524.80K | 524.80K | 526.60K | 526.60K | 490.90K |
Total Accrued Expenses | 489.90K | 489.90K | 577.90K | 577.90K | 414.50K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 122.40K | 122.40K | 123.40K | 123.40K | 118.40K |
Total Finance Division Other Current Liabilities | 27.20K | 27.20K | -- | -- | 32.40K |
Total Other Current Liabilities | 27.20K | 27.20K | -- | -- | 32.40K |
Total Current Liabilities | 1.16M | 1.16M | 1.23M | 1.23M | 1.06M |
|
|||||
Total Current Liabilities | 1.16M | 1.16M | 1.23M | 1.23M | 1.06M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 238.70K | 238.70K | 304.10K | 304.10K | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 684.10K | 684.10K | 218.90K | 218.90K | 411.90K |
Total Liabilities | 2.09M | 2.09M | 1.75M | 1.75M | 1.47M |
|
|||||
Common Stock & APIC | 9.30K | 9.30K | 5.30K | 5.30K | 23.89M |
Retained Earnings | -3.03M | -3.03M | 1.26M | 1.26M | -21.35M |
Treasury Stock & Other | 9.59M | 9.59M | 5.05M | 5.05M | 5.13M |
Total Common Equity | 6.57M | 6.57M | 6.32M | 6.32M | 7.68M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.57M | 6.57M | 6.32M | 6.32M | 7.68M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.57M | 6.57M | 6.32M | 6.32M | 7.68M |
|